MYC and cancer: Lack of SIRT6 in pancreatic ductal adenocarcinoma (PDAC) determines hyperacetylation of H3K9 and H3K56 at the promoter of the oncogene Lin28b, along with c-Myc recruitment, resulting in the enhancement of cancer progression and metastatization [65].